AU6216573A - 3-(4'-bromophenyl-3-(3"-pyridyl)-1-(dimethylamino)-propane or 3-3-(4'-dibrom ophenyl)-3-(3"-pyridyl)-1-(dimethylamino)-propane and their therapeutically acceptable acid addition salts - Google Patents

3-(4'-bromophenyl-3-(3"-pyridyl)-1-(dimethylamino)-propane or 3-3-(4'-dibrom ophenyl)-3-(3"-pyridyl)-1-(dimethylamino)-propane and their therapeutically acceptable acid addition salts

Info

Publication number
AU6216573A
AU6216573A AU62165/73A AU6216573A AU6216573A AU 6216573 A AU6216573 A AU 6216573A AU 62165/73 A AU62165/73 A AU 62165/73A AU 6216573 A AU6216573 A AU 6216573A AU 6216573 A AU6216573 A AU 6216573A
Authority
AU
Australia
Prior art keywords
pyridyl
dimethylamino
propane
dibrom
ophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU62165/73A
Other versions
AU484836B2 (en
Inventor
Hans Rudolf Corradi Peder Bernhard Berndtsson Per Arvid Emil Carlsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Application granted granted Critical
Publication of AU484836B2 publication Critical patent/AU484836B2/en
Publication of AU6216573A publication Critical patent/AU6216573A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62165/73A 1972-11-16 1973-11-05 3-(4'-bromophenyl-3-(3"-pyridyl)-1-(dimethylamino)-propane or 3-3-(4'-dibrom ophenyl)-3-(3"-pyridyl)-1-(dimethylamino)-propane and their therapeutically acceptable acid addition salts Expired AU484836B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7214872A SE373850B (en) 1972-11-16 1972-11-16
SESE14872/72 1972-11-16

Publications (2)

Publication Number Publication Date
AU484836B2 AU484836B2 (en) 1975-05-08
AU6216573A true AU6216573A (en) 1975-05-08

Family

ID=

Also Published As

Publication number Publication date
DK137898C (en) 1978-11-20
CA976553A (en) 1975-10-21
GB1429068A (en) 1976-03-24
FR2206942A1 (en) 1974-06-14
IE38516B1 (en) 1978-03-29
FR2206942B1 (en) 1977-01-28
FI55652C (en) 1979-09-10
DK137898B (en) 1978-05-29
AT333278B (en) 1976-11-10
CH586679A5 (en) 1977-04-15
JPS5732058B2 (en) 1982-07-08
AR204160A1 (en) 1975-11-28
NL7315294A (en) 1974-05-20
ATA938573A (en) 1976-03-15
BE806228A (en) 1974-02-15
FI55652B (en) 1979-05-31
DE2356017A1 (en) 1974-06-06
IE38516L (en) 1974-05-16
ES420359A1 (en) 1976-04-01
JPS49133379A (en) 1974-12-21
ZA737973B (en) 1974-10-30
SE373850B (en) 1975-02-17
SU482945A3 (en) 1975-08-30

Similar Documents

Publication Publication Date Title
ZA732633B (en) New 1,4-dihydropyridine carboxylic acid compounds,their production,and their medical use
NO157979C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE BENZOTIAZINE Dioxide SALTS.
CA999589A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
NO138566C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,1,3-BENZOTIADIAZOLE DERIVATIVES
YU318172A (en) Process for obtaining the novel compound 1-(2-hydroxy-4-carboxy-methoxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyll)-propane-1-one and physiologically acceptable salts thereof
AU476000B2 (en) 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts
PH11185A (en) Halogenated 3-(4'-biphenylyl)-butanols
CA964452A (en) Mason's guideline holders
GB1406882A (en) Benzoic acid derivatives and benzisptjoaup'e 1.1 dopxode derovatoves
AU484836B2 (en) 3-(4'-bromophenyl-3-(3"-pyridyl)-1-(dimethylamino)-propane or 3-3-(4'-dibrom ophenyl)-3-(3"-pyridyl)-1-(dimethylamino)-propane and their therapeutically acceptable acid addition salts
AU6216573A (en) 3-(4'-bromophenyl-3-(3"-pyridyl)-1-(dimethylamino)-propane or 3-3-(4'-dibrom ophenyl)-3-(3"-pyridyl)-1-(dimethylamino)-propane and their therapeutically acceptable acid addition salts
SE404190B (en) PROCEDURE FOR PREPARING 7 (ALFA-AMINO-P-HYDROXYPHENYLACETAMIDO) -3- (1-METHYL-5-TETRAZOLYLTIOMETHYL) -3-CEFEM-CARBOXYLIC ACID AND 7 (ALFA-AMINO-P-HYDACLYMIDYL-THYLETHYL -1,3,4-THIADIAZOLE-2-YLTIOMETHYL) -3-CEFEM ...
BE798814A (en) PERFECTED JOINT DRIVE
AU476756B2 (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID
NO137233C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALFA, ALFA-DIARYLIMIDAZOLE-2-METHANOLS AND ACID ADDITIONAL SALTS THEREOF
AU465880B2 (en) 6, 7-dihydro-17-hydroxy-3-oxo-3' h-cyclopropa 6,7-17-pregn-4-ene-21-carboxylic acids and salts
CA885976A (en) N-(d-6-methyl-8-isoergolenyl)-n',n'-diethylcarbamide and physiologically acceptable salts thereof
CA980377A (en) Golfer's practice aid
AU466599B2 (en) MANUFACTURE OF L. l'DIALKYL-4. 4'BIPYRIDYLIUM SALTS
CA866853A (en) 3,4,5-trimethoxy-benzamido alkanoic acids and their pharmaceutically acceptable salts
IE36928B1 (en) 6,7-dihydro-17-hydroxy-3-oxo-3'h-cyclopropa(6,77-17alpha-pregn-4-ene-21-carboxylic acids and salts
CA908165A (en) Process for the manufacture of new benzoxazepinones and therapeutically acceptable acid addition salts thereof
CA909786A (en) Carboxylic acid (1,2,4-thiadiazolyl-5)-amides
IL38870A0 (en) Racemic and optically active 1-(2,5-dichlorophenoxy)-3-tert-butylamino-2-propanol and its salts,their preparation and pharmaceutical compositions containing them
PH16419A (en) 7-(d-alpha-amino-alpha-(3'-methyl-4'-hydroxyphenyl)-acetamido)-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid,pharmaceutically acceptable esters and salts thereof